Protara Therapeutics/$TARA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Protara Therapeutics
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Ticker
$TARA
Sector
Primary listing
Employees
46
Headquarters
Website
TARA Metrics
BasicAdvanced
$229m
-
-$1.35
1.45
-
Price and volume
Market cap
$229m
Beta
1.45
52-week high
$7.82
52-week low
$2.77
Average daily volume
756k
Financial strength
Current ratio
15.691
Quick ratio
15.389
Long term debt to equity
0.989
Total debt to equity
1.687
Profitability
EBITDA (TTM)
-69.685
Management effectiveness
Return on assets (TTM)
-24.29%
Return on equity (TTM)
-37.27%
Valuation
Price to book
1.24
Price to tangible book (TTM)
1.24
Price to free cash flow (TTM)
-3.037
Free cash flow yield (TTM)
-32.93%
Free cash flow per share (TTM)
-1.34
Growth
Earnings per share change (TTM)
-17.29%
3-year earnings per share growth (CAGR)
-38.19%
TARA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs